株探米国株
英語
エドガーで原本を確認する
false000130178700013017872023-05-222023-05-22


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 22, 2023 (May 18, 2023)
 
BlueLinx Holdings Inc.
(Exact name of registrant as specified in its charter)
 
Delaware 001-32383 77-0627356
(State or other (Commission (I.R.S. Employer
jurisdiction of
incorporation)
File Number) Identification No.)
  
1950 Spectrum Circle, Suite 300, Marietta, GA
30067
(Address of principal executive offices) (Zip Code)

 
Registrant's telephone number, including area code: (770) 953-7000
 _________________________________________________
(Former name or former address, if changed since last report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share BXC New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





Item 5.07    Submission of Matters to a Vote of Security Holders         

On May 18, 2023, BlueLinx Holdings Inc. (the “Company”) held its Annual Meeting of Stockholders (the “2023 Annual Meeting”) to: (1) elect nine directors to hold office until the Company’s 2024 Annual Meeting of Stockholders, or until their successors are duly elected and qualified; (2) ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the Company’s current fiscal year ending December 30, 2023; (3) approve an advisory, non-binding resolution regarding the executive compensation described in the Company’s Proxy Statement for the 2023 Annual Meeting; and (4) conduct a non-binding, advisory vote on the frequency for future advisory votes on executive compensation.

At the close of business of March 24, 2023, the record date for the 2023 Annual Meeting, an aggregate of 9,061,849 shares of the Company’s common stock were issued and outstanding. At the meeting, 7,179,448 shares of the Company’s common stock were represented in person or by proxy; therefore, a quorum was present.

At the 2023 Annual Meeting, the Company’s stockholders voted as follows:

(1) For the election of the below-named nominees to the Board of Directors of the Company:

Nominees Number of
Votes For
Number of
Votes Withheld
Broker
Non-Votes
Anuj Dhanda 5,923,536 180,202 1,075,710
Dominic DiNapoli 5,344,837 758,901 1,075,710
Kim S. Fennebresque 5,219,083 884,655 1,075,710
Keith A. Haas 5,918,825 184,913 1,075,710
Mitchell B. Lewis 5,421,908 681,830 1,075,710
Shyam K. Reddy 5,928,738 175,000 1,075,710
J. David Smith 5,904,967 198,771 1,075,710
Carol B. Yancey 5,737,206 366,532 1,075,710
Marietta Edmunds Zakas 5,928,468 175,270 1,075,710

(2) For the ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the Company’s current fiscal year ending December 30, 2023:

For Against Abstain
7,172,809 2,373 4,266

(3) For the approval of the advisory, non-binding resolution regarding the executive compensation described in the Company’s Proxy Statement for the 2023 Annual Meeting:

For Against Abstain Broker Non-Votes
5,891,038 175,252 37,448 1,075,710

(4) On a non-binding, advisory basis, approved one year as the frequency for future advisory votes on executive compensation:

One Year Two Years Three Years Abstain Broker Non-Votes
5,659,123 4,059 437,314 3,242 1,075,710

Accordingly, the Company’s stockholders elected the nine director nominees and approved proposals 2 and 3 and approved one year for proposal 4 at the 2023 Annual Meeting.





Item 9.01     Financial Statements and Exhibits

(d)        Exhibits:

The following exhibits are attached with this Current Report on Form 8-K:

Exhibit No.   Exhibit Description
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)




SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
       
    BlueLinx Holdings Inc.  
     
       
Dated: May 22, 2023 By: /s/ Shyam K. Reddy  
    Shyam K. Reddy  
    President and Chief Executive Officer